Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SNTF (cleaved spectrin) Rabbit anti-Mouse, Porcine, Human, Unconjugated, Polyclonal, MilliporeSigma™
Rabbit Polyclonal Antibody
Supplier: MilliporeSigma ABN226450UL
Description
Anti-SNTF (cleaved spectrin), Cat. No. ABN2264, is a highly specific rabbit polyclonal antibody that targets cleaved Spectrin alpha chain, non-erythrocytic 1 and has been tested for use in ELISA, Immunohistochemistry, and Western Blotting.
Specifications
SNTF (cleaved spectrin) | |
Polyclonal | |
Unconjugated | |
Spectrin alpha chain non-erythrocytic 1;Alpha-II spectrin;Fodrin alpha chain;Spectrin non-erythroid alpha subunit;Calpain-derived alpha-II spectrin N-terminal fragment | |
Rabbit | |
∽160 kDa observed. Calculated molecular weight of full length protein is 284.54 kDa. Uncharacterized bands may be observed in some lysate(s). | |
50 μL | |
Neuroscience | |
NP_003118 | |
Mouse, Pig, Human | |
Antibodies | |
IgG |
ELISA, Immunohistochemistry, Western Blot | |
Please refer to lot specific datasheet. | |
Rabbit polyclonal antiserum with 0.05% sodium azide. | |
SPTAN1;NEAS;SPTA2 | |
KLH-conjugated linear peptide corresponding to calpain-generated neoepitope in SNTF (CAQQEVY). | |
Unpurified | |
RUO | |
Primary | |
This rabbit polyclonal antibody specifically detects calpain-generated neoepitope in SNTF. It targets a neoepitope of 6 amino acids at the carboxyl-end of the stable calpain-derived alpha-spectrin. | |
Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance. | |
Serum |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction